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ABSTRACT
Several 1- alkylbenzoylpyridinium halides containing
alkyl side chains of ons to fifteen carbons wers screen e d
for pharmacological activity.

A comparison of potency was

based on the ability to produce mortality in 50 percent of
mjce (LD 5D)~
The following parameters

~ere

inv estigated in a

select number of compounds representative of the series:
acute intraperitoneal LD50 in rats;
rats;

EDSO (hypo tensive) in

effects on the autonowic nervous system of anes-

th etized cats and dogs as indic ated by alteratio11s in
blood pressure;

effects en the nictitating membrane in

anesthetized cats;

direct effects upon blood vessels

employing hind quarter perfusion in intact rats;

effects

on the isolatec perfused guinea pig heart.
In mice the trend of acute intraperitonsal toxicity
was biphasic.

~he

methyl salts were the least to xic ,

while toxicity sharply increased with the ethyl salts.
As the carbon substitution incre ased to seven, toxicity
decreased.

Further carbon substitution led to a progres-

sive i~cre ase in toxicity.

Although fewer co mpounds were

tested in rats, the LD50 1 s approximately paralleled those
of the miceo
3-Benzoyl-1-ethylpyridinium iodide (3-C2-I),
i

3-benzoyl-1-octylpyridinium bromide (3-CB-Br), and
3-benzoyl-1-pentadecylpyridinium bromidE ( 3-C15-Br)
produced hypoten s ive effects in aneEthetized rats.

The

ED50 ( hypotensive) i~creased in that order.
Demonstration of hypot e nsive responses in anesthetized rats led to an investig ation of the mechanism of
t his action&

Decreas e d responses to carotid occlu s ion

and vag a l stimulation 2nd increesBd respo nse s to inject ed
epinephrine in anesthetized c at s and dogs suggested th a t
the 3-C2-I and 3-CB-Br exerted a hypotensiv e responEe
through gang lioplegia.
3-C2-I.

3-CB-Br was more potert than

rurth er testing of

3-C15-~

this time as respiratory failure

was discontinued at

follo we ~

by cardia c

arrest occurred, app a rently due to excessive qu an titi es of
f luid in the respiratory passages.

3-Benzoyl-1-dodecyl-

pyridinium bromide also elicited this response.
The ability of 3-C2-I and 3-CB-Br to block the
normal response of the rictit a ting membrane in c a ts by
electrical stimclation of the
sym~ath e tic

nerve was

test ed~

pre~ ang lionic

3-CB-Br was

cervical
~ore

potent th a n

3-C2-I in this test.
The flo w rates of perfusions of th e hind quarter
vascul ature of th e intact rats were

unaffecte~

up to the equi va l ent ED 5 0 (hypot ensive )e

by doses

3-C2-I an d

3-C B-Br sl1o we d c ard iodepressa nt and cardiotoxic effects
on the i solated

g~inea

pig heart, although a direct do se
ii

effect relationship could not be shown.

3-CB-Br was more

potent than 3-C2-I in producing cardiac arrest.
The results of these experiments support the
hypoth esis that 3-C2-I and 3-CS-Br exart a hypotensive
effect thro ugh ganglioplegia 1 un abet ted by direct vasodil ation.

A depressant action on the heart may contribute

to the hypotension induced by ganglioplegia.
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Io

INTRODlCTION

Some 1-alkyl-3-benzoylpyridinium halidee were
synthesized in 1967 by the Departmert of Pharmaceutical
Chemistry, University of Rhode Island, College of Pharmacy,
Kingston, Rhode Islando

The most distinctive chemical

feature of pharmacological interest of th ese compcunds is
the quaternary ammonium moiety.
were designed

ES

Although these

co~pouncis

molluscicidal agents, it was felt that

they might exhibit properties similar to other quaternary
ammonium

c~mpounds,

such as ganglioplegia, skeletal

muscle relaxation, or other autonomic effectso
The

syst em and

possibility of 5ffects en the cardiovascular
autonom~c

nervous system led to the screening

of th ese compounds with various tests de signed to show such
actions.
The r esults of this study may indic ate a possible
therapeutic v alue of these agents as well as relative
dan ger or safety when

e~plciyed

as molluscicidal agents.

7

II.

REVIEW

QC THf LITERATURE

In the course of the nineteerth c entury, which
encomp2sses the era of development and growth of the field
of synthetic organic pharmaceuticals, many natural products
WEre i solated 1 purified and their chemical structure
det ermined.

When it becam e apparent that cert a in similar

stru ctural moieties were somEtimes present in compounds
po ssessing related pharmacocynamic activity, this observation was seized upon as the only available guide for future
research.
d~ug

The modification cf the structure of a promising

co mpound is still the wain approach to producing new

drugs.

Sinc e structural . variations in a compound may not

alter all actions of the drug equally, the therapeutic
utility of a compound may be enhanced by developing a
cong ener whose therapeutic index is greater than that of
the parent compound.

Physical changes ·a ccomp a nyini;

structural variations may bring i mprovemerts in solubility,
vol atilit y, color and odor which may increEse the utility
of a given compound (B urger, 1960; Wilson and Gisvold,
1962).

Therapeutic a lly and experimentally valuab le drugs

hav e been develop e d which are structurally related antagon i s t s o f o t her . d r u r;.s ( Ha r t tl_a 1 • , 1 9 4 4 ) or o f ch em i ca 1 s
i mportant in bioche mic a l or physiologic al function (Farber
et al., 194 8 ; Symposium, 1954) • . ·

8

It has been hoped that the action of different drugs
might be explained on a unified basis thus allowing format ion of general principles guiding the rational development
of utilitar·ian new drugs with predicted and select pharmacological properties.

Largely

unsu~cessful

attempts were

made to relate a particular functional group to a particular
p harmacological effect ( Burger, 1958 ) .

Many compounds un-

related chemically elicit the same pharmGcologicel action,
particularly amen£ the CNS depressants ( Burger, 1960 ) .
Conversely, many compounds containing the same functional
group show a divergence of action, such as the sulfonamides
which have bacteriostatic ( Northey, 1948), hypoglycemic
(L oubatieres et ale, 1955; Editorial, 1956) 1 diuretic

( Krsbs, 1 948; Miller et alo 1

1 ~50 ) and artificial sweet-

ening properties ( Schutz et al., 1 957 ) .
The difficulty in finding a relationship among
c ompounds having similar biological actions but different
chemical structures, and the converse, does not negate
t he

significa~ce

of structure activity relationships.

To

t he contrary, it emphasizes the complexities of biological
systems, the limitations of our
mechanis~s

kno~ledge

of the basic

of drug action and that dregs may produce

overtly similar responses by mo r e than one mechar.ism.
Even the more advanced theories of isosterism
( Erlenmeyer et al., 1932; Friedman, 1951) and interference
with drug metabolism (Bradys 1955) have not shown

9

regularities in

st~ucture

activity relationships that

c ould be transferred indiscriminantly from one group of
c ompounds to the next.

However, the most pronounced

r egularities could be expected in a series of closely
analogous compounds.

This is demonstrated in an homologous

s eries since the regularities

~esulted

from gradual physical

ch anges ( Ferguson, 1939; Hansch, 19E6 ) .
" In 1 869? Crum-Brovm and Fraser observed that
t ertiary amines with varying pharmacological properties
t ended to show similar properties when quaternized 11 ( Wilson
a nd Gisvold p. 4, 1 962)0

Thus, although the literature

r eports no pharmacology of the 1-alkyl-3-benzoylpyridinium
halides , the presence af a quaternary ammcnium group might
i mpart known characteristics of other quaternary
Among the

com~ounds.

aramonium compounds are anti-

~uaternary

bacterial agents (L.awrence, 1958) ( disinfectants, antis eptics or sanitizers ) such as benzalkonium chloride and
cst ylpyridinium chlorideo

Other _quaternary ammcnium

c ompounds have anticholinergic properties which have found
u se es antisecretory , antispasmodic and antiulcer drugs
( Bachrach, 1958; Kirsner ~t ·a1. , 1953 ) .

Many of these

drugs are quaternary ammonium de rivatives Gf atropine,
scopolamin e , and papa verin e.

Curariform activity is

elicited by certain quatern ar y ammonium compounds ( Barlow
et al., 1948 ; Cast illo

.£.L21.•,

1950)

l

whi_le othors, such

as necstigmine, are cholinesterase inhibitors or curare

10

antagonists (Acheson et al., 1946; Wien et al., 1952)0
Althoug h a superficial inspection supports the
assumption of a diverg e nc e of biological actir.n among the
quaternary ammonium salts, the common factor is the
structural resemblance to acstylcholine, more specifical ly,
the quaternary ammonium group.

Since acetylcholine

mediates nervous trans111ission at various sites in the bo_dy
( Triggle, 1965), a structural congener of acetylcholine
msy mimic its act ion at these various sites, may antagonizs
acetylcholine or may inhibit cholineeterase 1 which deactiv ates acetylcholine.

If its absorption and distribution

p ermits, it may exhibit those

c:~ctions

at more than one site.

Since multiplicity of pharmacodyn am ic behavior int erferes
with the utility of many of th ese drugs ( Issekucz 1 1954)r
structur al modifications may lead to a higher specificity
of actior..
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III.
A.

INVESTI GATION

OBJECTIVES

The overall objectiv e of thi s inv estigation was to
evaluate th e ph arma cology of some benzoylpyridinium salts
1n mc:1mmals.
The specific o bject iv ss of this investi gation were:
1.
dinium

To screen a series of synthetic benzoylpyri-

s~lts

2.

for pharmacological

activity~

To relate the activity to the structural

arrang ement of thH compounds screened.
3.

To study in det ai l a select number of th ese

compounds in an attempt·to determine the pharmacological
site of action.
B_.

COMPOUNDS

The

follo~ing

compounds were used in this investiga-

tion and will hereafter be denoted by"the ebbreviat ions
shown in parenthesis :

3-ben zo yl-1 -met hylpyridinium iodide

( 3-C1-I); 3-b enzoy l-1- eth ylpyridinium iodide (3-C2-I);
3-benzoyl - 1 -propy~ py ridinium iodide (3-C3 - I);

3-benzoyl-

1-butylpyridini um bromide (3-C 4-Br); ~-b enzo yl - 1-pentyl
py ridinium bromide ( 3-C5-Br ); 3-benzoyl-1-heptylpyridinium
bro mi de (3-C?- Br ); 3-benzoyl-1-octylpyridinium bromide
(3-C B-Br ); 3-benzoyl-1-nonylpyridinium bromide (3-C9- Br );
3-b enzoyl-1-decy l pyridinium bro~ide (3-C10- Br); 3-benzoyl-

12
1-dodecylpyridinium bromide ( 3-C12-Br); 3-bsnzoyl-1-pentadecylpyridi niu~

bromide (3 -C15-Br ); 4-benzoyl-1-methyl-

pyridinium iodide ( ~-C 1~I'; and 4-benzoyl-1-ethylpyridinium
iodid e (4 - C2-l)o
All of th e compounds were solids and most of them
wer e fre ely soluble in water.

All co mpounds were admin-

ister ed in aqueous solutiono
The compounds were reported to be pure excspt for
3-C2 -I , which was 91 percent

pure~

The doses reported

thro ughout the inv estigation were uncorrected for the
impu rity, i.e.

1

the doses wsre reported as if the compound

were pure.,
Co

ANIMP.LS
1.

Mice:

River strain 1
2o Rats:
Riv er strain 2

Male and female albir;o mice of the Charles
were eIT'ployed for the acute toxicity studies.
Male and female albino rats of the Ch arles
WETS

employed for the acute toxicity studies

and the rind leg perfusion studies, while male 2lbinc rats
of the same strain were employed for the blood

~ressure

studieso
3.

Guin ea pigs:

Mongrel guinea pigs of either sex

were eIT'ployed for all isolated heart studieso
4.

Cats:
1

2

Mongrel c a ts of either sex were employed for

Ch arles River Breeding Farms, North
Ibid.,

Wilmin~ton ,

Mass.

13
blood pressure studies and for the nictitating membrane
prep arations ..
5.

Dogs:

Mongrel dogs of either sex wsrs employed

for blocd pressure studies.
D.

INSTRU MENTS
The E&M Physiograph 1 and its accessories were used

for all electronic recordings.
E.

EXPERIMENTAL PROCEDURES AND RESULTS
The investigation was divided into six sections:
1.

Th e acute intraperitoneal toxicity of the

1-olkyl -3- and 1-alkyl-4-benzoylpyridinium halides in mice;
th e acute intraperitoneal toxicity of 3-C2-I, 3-C4-Br,
3-C5-Br, 3-CB-Br and 3-C15-Br in rats.
2.

The effects of 3-C2-I, 3-CB-Br and 3-C15-Br

upon the blood pressure of rats.
3.

The effects of 3-C2-I, 3-CB-Br, 3-C12-Br and

3-C15-Br upon the autonomic nervous system employing
c2rdiov ascular tests in cats and dogs.
4.

The Effects of 3-C2-I and 3-CB-Br upon the

nictitating membrane of the cat.
5.

Th e effects of 3-C2-I and 3-CB-Br upon the

hind quarter vasculaturs of the intact rat.
6.

The effects of 3-C2-I and 3-CB-·Br upon the

i solated guinea pig hEar t.
1

E&M In st rumeGt Comp an y, Inc., Houston, Texas
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1.

~~

Intra peritoneal Toxicii.'i 9i_ the 1-Alkyl -3-

~

1-Alkyl-4-benzoylpyridiflium Halides in Mice and Rats
a)

Ex perimental Procedures
Fifty albino mice weighing 19g to 40 g and fifty

albino rats weighing 150 g to 400 g were divided into five
groups ec.ch cc ntaini ng equal numbers of both sexes 1 exc_e pt
0

wh E1re noted.,
In dividual drugs, 20 mg/ml as the salt or suitable
dilu t io ns thereof prepared in distilled water , were
administered intraperiton eall y.

The enimals were observed

fo r 24 hours and general sympto ms and tim e of dec th reco rded.

No animal was used more than once throughout the

entire stcdy.
Th e doses were
int ervelso

space~

in approximate ly log ar ithmic

Dos age was adjusted according to the results

obt ained, in order to determine the do se of a particular
c om~oun~

that would produc e de at h in 50 percent of the

animals (L D50 ) o

The dose and rESRonse were subjected to the

Li tchfield 2nd Wilcoxon (1 948 ) method of evaluatiflg doeeeff ect experiments.

Th e results were plotted and the LD50

graphic2lly calculated.
The co mpounds were co mpared on the basis of their
mg/k g LD 50 and their mM/kg LD 50.
b)

Results
The results incl ude the following: .
(1)

A co mparison of the LD50 of the various

15

compcunds (T able 1).
(2)

A comparison of tl1e mM LD50 versus the rumber

of carbons in the side chain (Fig: 1).
(3)

The compounds cont a ining from one to eight

carbors in the alkyl side chain were found to be short
acting , as ceeth or recovery occurred in 1 hour.

Higher

members of the series were found to be longer acting , with
death or recovery requiring a 24 hour period.
The gsneral symptGms produced ty al l the drugs in
both species were the same, i.e.,

slu~gishness,

decreased

acti vity, mydri a sis, loss of righting reflex as death
approached , an d dyspnea followed by convulsions and death.

TABLE 1 ..

A compar i son of the LD50 of some 1- alkyl - 3- and 1- alkyl - 4- benzoylpyridinium
halides in mice and rats

e

0

rQr 3-rQY- RX
Isomer

R

x

ice
LD50 + 0.95
Confidence Limitsa
( mg / kg)
!Yi

(mlYl/kg)

Rats
LD50 + 0.95
Confidence Limitsa
( mg /kg)

( mlYl /kg)

127 (113-142)

0.375

3

CH3

I

84 (73-104)

0.285

3

C2H5

I

46 (39- 55)

o.136

3

C3 H7

I

55 (51 - 60)

o.156

3

C4H9

Br

86 (79- 94)

0.269

180 (1 58 - 2.05)b

0.563

3

C5 H11

Br

90 ( 84 - 96)

0.270

227 (207 - 249)b

Oo680

3

C7H15

Br

103 (97 - 109) .

0.284

3

C8H17

Br

90 (78-110)

0 .. 244

40 ( 36 - 44)

0.106

3

C9H19

Br

67 (59- 76)

0.156

3

C10H21

Br

46 (48- 53)

0.114

3

C12H25

Br

38 (33 - 44)

0 .. 088

3

C15H31

Br

3,g ( 33- 44)

Oo080

44 ( 31 - 63)

0 .092

4

CH 3

I

110 (94-129)

Do338

4

C2H5

I

15 (11- 21)

Do044

aCalculated From the Litchfield

and

Wilcoxon ( 19 48 )'method.,

bThrae groups of 6 animals were used instead of usual 5 groups of 10 animals.
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NUMBER OF CARBONS IN SIDE CHAIN
Fig. 1.

Strccture Activity Relationship of the 1-Alkyl-3-benzoylpyridinium

Halides~
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2.

Effects of 3-BeD3.9.:d.=J-ethy lpyridini um Iodid e (3-C2 - I),
3-B enz oyl-1-oct ylpyrid in iu m Bromide ( 3-CB-Br ) and
3- Ben .z o y 1- 1 -p 8 n t ad E: c y 1 p yr i d i n i um 8 r om i de ( 3- C1 5 ·· 8 r )
.QD_

the Blood Pr essure .Q.f. Rats

Experim~nta l Proc edures

a)

Th e effects of the compour.ds on the blood pressur e of
mal e albino rats we i ghing between 300 g and 475 g were
reco rded wanometri c a lly by direct c annulation of the l eft
c arotid

artery~

A normal saline, fluid bridge in tygon

tubi nq c onnected the cannula to a mercury manometer.
Blood pressure responses were recorded cm a s] owly moving
s ~oked

kymogrciph.
Rats were anethetized with urethane , 1 ~2 g /k ~ of a

fr eshly prep a rec 20 percent solution, administered in trap eritoneall y via the ri ght f emora l ve in.

To prev e nt

clottin g, heparin sodium 1 0 .1 ml of a 1:10 .ooc solution ,
wa s

ad~inistered

to each rat prior to cannulation .

si milar conc en tration of hep ar in

s odiu~

A

was placed i nt o the

c a nnul a.
A minimu m of 10 minutes

~as

a llo ~~d

to elapse prior

to dr ug administration to p erm it sta bi li zat ion of th e blood
pr essure.

One drug was sdministered per anima l and no more

th an a tot a l of 4 inj ect ion s were a dminist sred to on e anima lo
Foll owing each inj ect ion the blood pressure was a llo wed to
return to no rmal be fore a second inj ect ion

~as

made.
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Doses were adjusted to detGrmine the dose of a
compound th at would produce an approximate 50 perc ent
decre ase in blood

pressure~

The doss and response was

subjected to ths Litchfi eld an~ Wilcoxon (19~8) method of
evaluating dose-effect experiments.

The results were

plotted and the ED50 (hypot ensive ) calculated.
The compounds were

co~pared

using the following

indic es of activity:
(1)

The percent decrezse in blood pressure produced

by different doses of the compounds.
(2)

The duration of the hypotensive effect, i.e.,

time elapsed before the arterial blood pr essure returned
to 90 percent of the normal blood pressure.
(3)
a 50

~ercent

The dose of the compound required to produce
decrease in arterial blood pressure, i.e.,

ED50 (hy potensive).
b)

Results
The results includ e the
(1)

followi~g:

Effects of 3-C2-I, 3-CB-Br and 3-C15-Br on

the arterial blood pressure of male albino rats ( Tables 2
to 4).
( 2)

A comparison of the effects of 3-C2-I, 3-CB-Br

and 3-C15-Br on the arterial blood pressure of male albino
rats (T able 5).

TABLE 2.

Effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I) on the blood pressure of rats

Dose
(mg/kg)

Number of
Trials

Mean %Drop
in Blood
Pressure
.±. S.D.

Duration of
Drop
(fYlean and Range)
(Min.)

2,0

2

12 .±. 2

3.0 (2.7-'.1.3)

3.0

2

15 .±. 5

3.2 (3.0-3.4)

6.0

1

22

3.2

10 .. 0

3

26 .±. 3

3.4 (2.7-4.0)

20.0

4

34 .±. 2

3 .. 3 (3,.0-4.2)

25.0

4

40 .±. 7

3,6 (3.3-4.0)

30.0

4

45 .±. 4

3.3 (2.5-3.6)

N

0

TABLE 3~

Effects of 3- benzoyl - 1- o c t yl p yridinium br omide (3 - C8 - Br ) on the blood pres sure of rats

Dose
(m g/ kg )

Number of
Trials

Mean % Drop
in Blood
Pr.essure
+ S .. Do
-·

Duration of
Drop
(!Ylean and Range)
(!Ylin.)

2n5

3

34 ±. 1

3.6 (3.0-4.2)

5 .0

6

39 ± 3

4.4 (3.2 - 5.2)

7 .. 5

3

43 ± 3

5.0 (4.0 - 6.0)

10.0

4

48 ± 3

6 •.9 (6.0 - 8 .2)

N

_,_

TABLE 4.

Effects of 3-benzoyl-1-pentadecylpyridinium bromide (3-C15-Br) on the blood
pressure of rats

Number of
Trials

!Ylean %Drop
.in Blood
Press ure
.±. S.D.

Duration of
Drop
(!Ylean and Range)
(!Ylin.)

1.0

2

24 .±. 1

3.5 (3.0 - 4.0)

2.0

2

32 .±. 1

7.3 (4.6-10.0)

3.0

2

42 ±. 1

10.8 (5.6-16.0)

5.0

1

43

7.0

2

48 .±. 1

13.5 (9.0-18o0)

10.0

1

54

20~0a

Dose
( mg /kg)

8

6.2

Did not recover to 90 porcent of normal within 20 minutes; terminated ..

N
N

TASLE 5.

A comparison of the ED50 (hypotensive) of the 1-alkyl-1-benzoylpyridinium
halides on the blood pressure of rats

Compound

3-Benzoyl -1- ethylpyridinium
iodide (3-C2-I)

Total
Trials

Calculated
ED50a
(mg/kg)

ED50
(m!Yl /kg)

20

52.0

0.153

. 16

14.0

0~037

10

8.1

0.017

3 - Benzoyl-1-octylpyridi~ium

bromida (3-C8-Br)
3- Benzoyl -1- pentadecylpyri diniu m bromide (3-C15-Br)

aDe rived from the Wilcoxon and Litchfield (1948) method of evaluating dose effect

experiments~

N

t.N

3.

Effects

.Qf 3-Benzoyl-1-ethylpyridinium Iodide (3-C 2-I ),

3-Ben zoyl- 1-octylpyridinium Bromide ( 3-CS-Br ),
3-B enzoyl-1-dodecylpyridinium ]romid~ (3-C12-Br)
and 3-B e nzoyl-1-pentadecylpyridinium Bromide
(3- C15-Br)

W
a)

Four Cardiovascul ar Tests in the

.Q.!J.

and the .Q.£g

ExR erimen tal ££oc edures
Mor~rel

cats of either sex weighing 2.5 to 3.5 kg and

mongrel dogs of either sex weighing 17 .5 to 19. 5 kg were
anesthetized with sodium pe ntobarbital, 35 mg/kg of a 3a5
percent solution, administered intraperitoneally and intraveno usly,

respectively~

Following c annulation of the left

femor 21 l artery, the blood pressure v1a s recorded on a calibrated

Physio~raph.

The cannula was connected via a fluid

brid ge of normal saline to a Bourdon typ e pressure transduc ero

All injections were mad8 into the right femoral

vein via a cannula connected to e buret containing norm a l
saline used to displac e the drug.
formed as part of thr

A trach eo to my was per-

procedure.

rorm~l

The commcn carotid

arteries were isolated and a Joose ligature

pass~d

under-

neath each.

When performing a bilateral ca rotid occlusion,

the

wes lifted and

ligatur~

caud a d to the bifur c at ior.

2

taped bulldog clamp secured

Care was t aken to avoid

unnec essary stretching of the arter y..

Th e c er vic a l portions

of th e vagal nerv es were then isolated, li gated and severed
cra niad to th e ligature.

Follo wing stabilizatio1 of the

25

preparation the following tests were performed:
(1) bilatera l occlusion of the comwon carotids-3 0
s ec.
(2) bilateral vagal stimulation- the intensity was
a djusted to obtain certain percent responses-20 sec.
( 3 ) epinephrine-the dose was adjusted to o btain
c ertain p ercent responses.
( 4 ) acetylcholine-the dose was cdjusted to o btain
c ertain percent

responses~

( 5 ) tests compound-the dose ~as adjusted t o obtain
c ertain percent responses.
( 6 ) repeat test ( 1 ) •

(7) repeat test ( 2 ) 0
( 8 ) r epeat test ( 3) .
(9) repeat test ( 4 ) •.

It should be noted that additional doses of a comp ound were

give~

when the effect was not of sufficient

d uration to complete the series of

tests~

Th e percent change i n blood pressure produced by
e a c h of t he test procedures before and after administration
of a compound was the index of activity studied.
b)

Results
The results include the follo wing:
(1)

by 3-C2-I
11 ) •

an~

Changes induced in four cardiovascul a r tests
3-CS-Br in the c a t and the dog ( Tab l es 6 to

26

( 2)

A comparison of the changes induced in four

c ardiovascular tests by thess compo~nds ( Table 12 ) o
( 3)

Whan 3-C12-Br and 3-C15-Br ware administered

t o cats , the blood pressure was low3rede
f ollowed, apparently dua to respiratory
l arge amounts af f lu:d

~n

the lungs.

Death soon
impair~e~t

fro~

The secretion of

f luid did not result from the use of acetylcholine as it also
appeared when these compounjs were administered to cats
p repared in the same surgical manner but which had not received any prior drugso

TABLE 6.

Effects of 3-ben zoyl -1-ethylpyr idinium iodide (3-C2- I ) on four c ar d i ovascular tests in the c at:
cat 1

Change in
Blood Pressure
(Ori(inal-P eak )
. mm Hg.)

% Change in
Blood Pressure

Bilateral carotid
occlusion (30 sec. )

120-190

+58

Bilateral va(al
stimulation 20 sece)

120- 80

-3 3

Test

Dose
(units/kg)

Epinephrine HC1

6.6 ug

120 -1 70

+42

Ace tyl choline HBr

0.3 ug

130 - 75

- 42

20.0 mg

1 25 -1 05

-1 6

Bilateral carotid
occlusion (30 sec.)

10 5-1 10

+ 5

Bilatere.l va(al
stimulation 20 sec.)

105-105

0

3- C2 - I

Epinephrine HCl

6 .. 6 ug

105-160

+52

Acetylcholine HBr

0.,3 ug

11 0- 70

-3 6

N
-.J

TABLE 7.

Effects of 3- bEnzoyl -1- ethylpyridinium iodide (3-C2-I) on four cardiovas cular tests in the ·cat:
cat 2

Test

Dose
(units/kg)

Change in
Blood Pressure
(Dri (inal - Peak)
mm Hg)

% Change in
Blood Pressure

Bilatera l carotid
occlusion (30 sec.)

160 - 210

+ 32

Bilateral va(al
stimulation 20 sec.)

160-130

- 20

Epinephrine HCl

0.8 ug

160 - 210

+ 32

Acetylcholine HBr

0.2 ug

160-110

- 31

3-C2-I

6.5 mg

160 -12 0

- 25

Bilateral carDtid
occlusion (30 sec.)

110 - 120

+

9

Bilate:-al vaaal
stimulation (20 sec.)

130 - 110

-

8

13. 1 m.g

160 - 80

- 50

0.8 ug

80 -1 60

+100

130 1 mg

15C - 75

- 50

Oo2 ug

70 - 50

- 29

3-C2-I
Epinephrine HCl
3-C2-I
Acetylchcline HBr

N

co

TABLE 8 .

Effects of 3-benzoyl-1-ethylpyridi nium iodide (3-C2-I) on four c ar diovasc ular tests in the dog:
do g 1

Change in
Blood Pressure
(Ori(inal-Peak)
mm Hg)

% Change in
Blo od Pressu re

Bilateral carotid
occlusion (30 sec. )

150-185

+23

Bilate ral va(al
stimulati on 20 sec.)

140-100

-28

Test

Dose
( units/kg)

Epinephrine HCl

2.5 ug

150-170

+13

Acetylcholine HBr

D.5 ug

130-105

-1 9

3- C2-I

8.5 mg

135-105

-2 2

occlu~ion (30 sec. )

130-130

0

Bilatera l va(al
stimulation 20 sec.)

130-130

0

Bilate rel carotid

Epinephrine HCl

2.5 ug

130-175

+25

Acetylcholine HBr

0.5 ug

125 -110

- 12

N
l.O

TABLE 9.

Effects of 3- benzoyl - 1-o ctyl py ridinium brom i de ( 3-C 8- Br) on four ca r d iovascular tests in the cat:
cat 3

Test

Dose
( units/kg )

Change in
Blood Pressure
(Ori(inal - Peak)
mm Hg)

% Change in
Blood ' Pressure

Bilateral carotid
occlusion (30 sec.)

190 - 280

+47

Bilateral vaoal
stimulation (20 sec.)

190 - 130

- 32

Epinephrine HC:l

0 .7 ug

180 - 210

+ 1'7

Acetylcholine HBr

o. 3

g

170 - 100

- 41

10 . 6 mg

170 - 80

- 53

Bilateral carotid
occlusion (30 sec . )

90 - 110

+22

Bilateral vaoal
stimulation (20 se c. )

90 - 75

- 17

3- CB-Br

t,.J

Epinephrine HC l

D. 7 ug

110 - 180

+63

Acetylcholine HBr

0,.3 ug

110 - 60

- 45

03
0

TABLE 10.

Effects of 3-benzoyl-1-octylpyridinium bromide (3-CS-Br) on four cardiovascular tests in the cat:
cat 4

Test

Dose
(units/kg)

Change in
Blood Pressure
(Ori(inal - Peak)
mm Hg)

% Change in
Blood Pressure

Bilateral c aroti d
occ lusion (30 sec.)

120-170

+42

Bi lateral vafal
20 sec.)

120 - 80

· -33

stimula~i o n

Epinephrine HC.1

0.8 ug

130 -190

+46

Ac etylcholine HBr

0.3 ug

150 - 80

- 47

13.5 rng

150- 80

-47

Bilateral carotid
occlusion (30 sec.)

8 0- 85

+· 6

Bilatera l vaoal
stimulati on (20 sec.)

80- 75

-

3-CS-Br

6

Epinephrine HCl

0.8 ug

8 0-140

+75

Acetylcholine HBr

0,..3 ug

80 - 40

- 50

CA

_.

TABLE 11.

EffBcts of 3-benzoyl ~1-oc tylpyridinium bromide (3-CS-Br) on four cardiovas~ul ar tests in the dogs
dog 2

Test

Dose
(uni ts/kg )

Change in
Blood Pressure
(Ori(inal-Peak)
.
mm ·Hg)

% Change in
Blood Pressure

Bilateral carotid .
occlusion (30 sec.)

140 -1 75

+ 25

Bilateral va~al
stimulation 20 sec.)

135 - 85

·- 37

Epinephrine HC.1

2o2 ug

135 - 160

+ 19

Acetylcholine HBr

0.6 ug

130 -1 00

- 23

3-CS - Br

6.7 mg

135 -10 0

- 30

100 - 105

+

Bilateral carotid
occlusion (30 seco)
Bilateral vaqal
stimulation (20 sec.)

5

95 - 95

0

Epinephrine HCl

2 .. 2 ug

95 - 200

+100

Acetylcholine HBr

0.6 ug

90 - 70

- 22

c.N
N

TABLE 12.

Animal

Cat 1
Cat 2
Dog 1
Cat 3
Cat 4
Dog 2

A comparison of the effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I)
and 3- benzoyl - 1 -octylpyridinium bromide (3-CB-Br)
on four cardiovascular tests in the cat and the d~g

Drug

Dose
(mg/kg)

None
3-C2-I

20 .. 0

None
3-C2-I

6 .. 5

None
3-C2-I

8.,5

Blood Pressure Changes
BCD

BVS

++
0

0

.+ .+.
++

0

.+.+
+++

0

. +.+
+++

++

None
3-C B- Br

10 <> 6

None
3-CB-- Br

13 .. 5

None
3-C B- Br

6.7

0
++

0

++
+

ACH

+++

0

.++
+++

.0

+++·

++

0

EPI

.. .+.+

++

0

a,b

++

aSymbols: +, rise; ++, marked rise; +++, severe rise; - , fall; -- 1 marked
fall; 0 1 no changeo
b

Abbreviations:
BCD, bilateral carotid occlusion; BVS, bilateral vagal
stimulation; EPI, epinephrine; ACH, acetylcholina~
(.,.l
(.,.l
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E f f e ct s · o f .3- Be n z o y 1-1 - et .b.1JB yr i d i n i um I o d i de ( 3- C2 - I )

Nictitati.Q_g Membrane £f.. .i!Je Cat
a)

Experimental Procedures
Mongrel cats of either sex weighing 2.5 to 3.5 k9

were anesthetized with a 3.5 percent solution of pentobarbital
35 mg/kg, administered intraperitoneally~

A tracheotomy ~as

perfo rmed as part of the normal procedureo

Following cannu-

lation of the left femoral artery, the blood pressure was
record ed on a calibrated Physiograph.

Th e cannula was

connected via a fluid br id ge of normal saline to a Bourdon
type pressure transducer.
right

All injections wEre made into the

femoral vein via a cannula connected to a buret con-

taini ng normal saline used for displacement of the drug.
The preganglionic cervical sympathetic nerve was
isol ated , ligated and severed caudad to the
superior cervical ganglion togethBr

~ith

li gature~

The

its postganglionic

fib ers was isolated and a ligature pass·ec undern t.: i e.th the postganglionic fiberso

The responses of the nictttating membrane

to electrical stimulation of the cervical sympathetic

.

.

nerve were recorded on a Physiograph by means of a myograph
B tr ansducer attached by silk thread, passing over a pulley
to the nictitating membrane.

The minimal intensity of

electrical stimL!lation reeded to produce a contraction of the
nic titating

me~brane

via stimulation of the pre- and post-

ganglioric sympathetic fib e rs

~as

determinedo

Th e test

35

compound was then administered.

The pre- and postganglionic

f ibers were stimulated during the effects of the drug as
determinEd by changes in blood pressure.
was allowed to return to normal&

The blood pressure

Responses of the nictitating

membrane to pre- and postganglionic nerve stimulation were
re-establi~h~d

b)

to insure the integrity of the preparationo

Results
The results include the following:
(1)

ThG effects of 3-C2-I and 3-CB-Br on the

nictitating membrane of the cat ( Table 13 ) .

TABLE 13 . Effects of 3- be nz oyl - 1- ethylpyridinium iodide (3-~2 - I) and 3- benzo yl - 1octylpyridinium brom i de (3 - CB-Br) on the nictitating me~brane of the cat

Animal

Drug

1

3-C2 - I

Dose
(mg/kg)

o.o
10 . 0

2

3- C2 - I

O~O

20.0
3

3- C2 - I

0~0

20.0
4

3- C8 - Br

o.o
8 .0

5

3- C8 - Br

o.o
10 . 0

a

Symbo l s :

+'

Chan gB in Blood Pressure
% Change
Ori(inal - Peak
mm Hg)

Response to Sti mu l at ion of a
Cervical S~mgathatic Nerve
Pr egang lionic
P o s t g an g 1 i on i .c

0- 0
120 - 60

0
- 50

++

0

++
++

0- 0
110- 70

0
- 36

++
+

++
++

0- 0
145- 90

0
·-38

++

++
++

0
O·180 - 120

0
- 33

++

0
O·80 - 50

0
- 38

·}-+

0
0
0

++
++
++
++

r ise; + + , marked rise; 0' no change.

(.,J

°'
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So

Effects

E.f. 3-Benzoyl-1-ethylpyridinium Iodide ( 3-C2-I )

and 3-Benzoyl-1-octylpyridinium Bro~ide (3-CB-Br) on
t h.§,_ Hind Quarter Vasculature of the Int act Rat
a)

Experim ental Procedures
Male albino rats weighing 330 g to 430 g were anes-

thetiz ed with sodium pentobarbital, 35 mg/kg of a 3.5 percent
solution,

ad~inistered

int raperitoneally.

was made from the pelvis to th e sternumo

A midline incision
Th e intestines werE

li fted cut of t he body c avit y and covered with qauze mcistened
in normal s a lin e.

Th e abdominal aorta and ven a cava were iso-

lated at the l eve l of the renel veins and li gated c audad to
therno

The aorta and ven a cava were cannu lated.

The cannulat ed eorta was conn ected by gum tubing,
capacity 6 ml, to a modified And ers on Craver 1 heart perfusion apparatuso

The preparation was stabilized at a

c onstant temperature of 35.5 degr ees centigrade, maintained
by a circul ating water bath.

A constant perfusion head pres

sure of approximately 60 cm of wa ter was maintainedo
pe r fusion fluid was aerated Locke-Ringer solution.

Th e
Du r ing

each experiment the perfusate was collect ed and discarded.
Hep arin sodium, Oo1 ml of a 1110 00 solution, was
perf used through the preparation.

When the perfusate was

cl ear , the cocnting wa s begun.
An electronic drop counter wa s used to r e cord the
1

Metro Industries, Lone Island City, New Yor k
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rate of effluence.

Following the recording of normal

effluence, drug administration was effected via an injection
spiral (1 .5 ml volume) connected to the perfusion c ana l ~
2.0 ml of perfusste was used to displace the drug.
The experimental procedure was standardized with a
2 minute control count$

When the volume of the effluent

equaled the total volume of the tubing, a 4 minute drug
effect count was tegunc

The highest dose used was chosen

to equal or exceed the intraperitoneal ED50 in ratso
high est dose used in the above experimsnts

~as

Th e

also tested

with a 15 minute drug effect interval and a 2 minute control.
A two tailed Student 's t test was used to test the significance of the data.
Only one drug was used per animal.

Not more than a

tot al of 5 doses was administered per preparation.

Each

animal was used for a period not exceeding 2 hours, due to
severe edema occurring after this period of time.
b)

Results
The results include the followings
(1)

The effects of· 3-C2-I and 3-CB-Br on the hind

quarter vascul a ture of the intact rat (T ables 14 and 15).

TABLE 15.

Animal

1

2

3a

Effects of 3-benzoyl-1-octylpyridinium bromide (3-C8-Br) on the hind
quarter vasculatur e of the intact rat

Dose
Equivalent
(mg)
(mg/k g )

Control
Drops/min. ± S.D.

Drug Effect
Drops/min~ .±. S.D.

pb

20

60.6

32.0 ± 2.0

37. 8 .±. 3.9

nos. b

20

60.6

35.0 .±. 1.0

41o0 .±. 9.,6

n.s.

10

30.3

18.0 .±. 1.0

17.3 .±. 1o1

n.s.

10

30.3

18.5 .±. 0.5

19.0 .±. 2.4

nose

20

6006

17.1 .±. 1.0

19.5 .±. 1.1

n.s.

20

55.5

31.5 .±.

39.0 .±. 6.1

n.s.

20

55.5

47.0 .±.

o.s
o.o

45.0 .±. 1.7

n.s.

a

Drug effect count taken f or 15 minutes after a 2 minute control counto
b
S ymb ols:
p ' 0 .01 le ve l of si g~if ic an c e; n .s., n ot s ignifi c ant .

J::..
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TABLE 14.

Effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I) on the hind
quarter vasculature of the intact rat

Animal

Dose
Equivalent
(mg)
(mg/kg)

1

pb

Drug Effect
Drops/Min • .±. S.D.

10

23.,3

251,.0 .±.

1o0

247 .. 3 .±.

6.2

n.s. b

20

46.5

'132.0 .±. 10.0

121.0 .±.

5.3

n.s.

5

13.0

84.0 .±.

0

E'i1-.3 .±.

2.6

nos.

10 .

26.0

125.5 .±.

9.5

110.0 .±. 10.,7

n.s.

20

52.0

123.5 .±.

1.5

124.0 .±. 11.°'7

n.s.

20

::408

114.5 .±.

7.5

11207 .±.

3.6

n .. s.

40

109 .. 6

71-oO .±.

5 ... 0

78.,6 .±.

3., 3

> 0. 05

2

3a

Control
Drops/Min. ± S.D.

1~

aDrug effect count taksn for 15 minutes after a 2 minute control count ..
b Symbols :

p ' 0.0 1 level of si gnificance; n .s., n ot significant.

(.,.J
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6.

Effects of 3-Bi::nzoyl-1-ethylpyridir.ium Iodide ( 3-C2-I )
and 3-Benzoyl-1-octyloyridiniu~ Bromide \ 3-CB-Br ) on
the Isolated Guinea
a)

£i..9.

Heart

Experimental Procedures
GuinEa pigs of either sex

were

s~crificed

by cervical

weighin~

dislocation~

a50 q to 950 g
FcJlowing a mid -

t horacic incision and retraction of the ribs, the heart was
prepared as follows:
\1)

The descending aorta was clamped and cut distally

in the are2 of ..thE diaphragm.
\ 2)

The major arteries, innominate, left subclavian,

and left common carotid, were severed thus freeing the aortao
( 3)

The inferior and superior veriae cavae were severed~

( 4)

The trachea was severed.

The heart with lungs attached, was then rapidly
removed and transferred to a dish of oxygenated perfusion
solution at room temperature.
~erfusion

Several ml of warm oxygenated

solution containing 0.1 ml of a 1:1000 solutior. of

sodium heparin were gently passed through the coronary
arteries via injection into the aorta to remove residual
blood and to prevent formation of clots within these small
blood vessels.

The aorta was cannulated with a glass cannula

with its tip proximal to the innominate artery and distal to
the coronary ostia

an~

SEcured.

The cannulated heart was then

transferred to an Anderson Craver heart perfusion apparatus.
A constant fluid level was maintained in the perfusion well;
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the siphoned fluid was collected by means of suction and
discarded.
A constant te mperature of

37~5

degrees c ent igrade

was maintained by use of a ~irculating wEter bath.

Following

stabilization of the preparation under a perfusion head
pressure of 55 cm of water, all extraneous tissue including
the pericardium was dissected freso

A stainless steel hook

was inse rte d into the v en tricul ar musculature at the heart's
apex and the glass ch ambe r secured.

A silk thread connected

the hook, through a pulley system, to a recording lever that
recorded the cardiac contraction s on a slowly moving smoked
kymograph.
The perfusion solution used was that recommen ded by
Ch enoweth and Koelle (1 946 ) modified by Smooklsr and Defeo
(19 62 )0
Fiv e liters of stock solution containin£ 350 g
sodium chlorid e , 21o0 g pct ass ium chloride, 15.9 g calcium
chlorid e dihydrate and 17. 8 g magnesium sulfate monohydrate
were prepared using deionized water and stored at room
temperat~r ee

The fin al perfu s ion fluid

~as

prepared for each

experiment by taking 346 g dextrose, 4.2 g of sodium ticarbon ate , 200 ml of

stoc~

solution and sufficient deionized

water to make 2 liters of solution.

Th e perfusion fluid

was oxygenated with a mixture of 95 perc en t oxygen and 5
perc ent carbo n dioxid e o

Th e pH of the final solution was
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70 80

During each experiment the perfusate was collected

and discarded.
Followin g the recording of norm a l cardi ac contr a ctions
drug administr a tion was effected via an injection spiral
conn ected to the perfusion canal, with a volume of perfusate
(2 .D ml) greater than that held by the spiral (1c 5 ml).
One compound was tested per preparation and not more than 6
injections were made on one pr e paration.

Succeedin~

doses

were adm i nistered after a lapse of 10 minutes from the time
of rBcovery from the previou s doseo
A depression of 95 percen t or more from the
was considered to be ca rdiac arrest.

nor~al

A depression of 50

to 95 perc e nt was considered to be severe CGrd iac depression
(SD), while 20 to 50 per~ent, mild cardiac depression ( MD),
0 to 20 percent, no

eff~ct.

Cardiac stimul a tion was con-

sider ed to have occurred if there was an increase of amplitude of 50 percent over the normal.
The indices of activity used to compare the compounds
were as follo ws :
(1)

The incid e nce of c a rdiac arrest at a particular

(2)

The incidence and severity of cardi ac dep res s ion

if no arrest occurred.
(3)

The incid ence of c ardiac stimulation if no

arrest occ urred.
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b)

Results
Th e results include the foll owing:
(1)

A profile of the effects of 3-C2-I and 3-CB-Br

on the isolated guinea pig hec.r.t (T ables 1 6 and 17).
( 2)

3-CB-Br. is c onsidered to be more toxic than

3- C2 - I; at 2e0 mg, 3-CB-Br produced three out of three
cardi ac arrests with no recoveries, while 3-C2-I at the same
do se produced one out of seven cardiac arrests with no recove r y an d fiv e out of seven se vere c ardiac depressions with
full recoveries.
(3)

In most trials resuJ.ting either i n cardiac

arrest or severe depression, a 2 to 3 second int erva l of
c ardiac stimulation preced e d the former events.
(4)

In one experiment using 3-C2-I at 1.0 mg,

th ere was one occurrence of cardiac stimulation only.
(5)

Employing 3-CB -Br there were 3 occurrences of

c ard i ac stimulat ion only, two at 0.6 mg, and one at 1.0 mg.

TABLE 16.

Profile of the effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I) on
the isolated guinea pig hea~t

Cardiac Arrest
Arrests/Trials

Dose
(mg/kg)

Recovery to
50% Normal
Recoveries /
Arrests

Cardiac Depression
Depressions/Trials
(if no arrest)

Recovery to
50% Normal
•
I
Recover1es;
Depressions

No Effect
No Effects/
Trials

0.02

2/2

0.1

1/1

0 .. 2

3/3
1/2 SDa

0.5
1. 0

1/4

0/1

2.0

1/7

0/1

4 .. 0
8

Symbol:

1/1

1/1
2/4b

5/7 SD

5/5

1/1 SD

1/1

1/7

SD, severe depression, 50-95 percent.

bone occurrence of ca~diac stimulation, >50 ~ercent.

J:>.
Ul

TABLE 17.

· Dose
(mg/kg)

Profile of the effects of 3-benzoyl-1-octylpyridinium bromide (3-CB-Br)
on the isolated guinea pig heart

Cardia c Arrest
Arrests/Trials

Recovery to
50% Norm3.l
Recoveries/
Arrests

Cardiac Depression
Depressions/Trials
(if no arrest)

Recovery to
50% Normal
Recoveries/
Depressions

0.02

No Effect
No Effects/
Trials

1 /1

o.. 2

1/5

1 /1

0.5

1/5 fYlDa

0/1

1/1 soa

0/1

3/5

0" 6

4/7

2/4

1/7 MD

0/1

2/7b

1.0

3/5

2/3

1/5 SD

0/1

1/0

2.0

3/3

0/3

20.0

1 /1

0/1

a.Symbols:
percent.

c

SD, severe depression, 50-95 percent; MD, mild depression, 20-50

bTwo occurrences of cardiac stimulation, >50 percent increase.
cOne occurrence of c ar diac stimula t ion, > 50 percent increase.

J::>.
er\
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IV. DISCUSSION
A.

ACUTE TOXICITY STUDIES
The acute ir.traperitoneal toxicity of several

1-alkyl-3-benzoylpyridinium halides was determined in
albino mice in order to test the possible existence of a
trend in toxicity paralleling a change in structure.

At

the same time, the gross syndrome was Gbserved in order to
provide information concerning a possible mode of action.
The mEthyl salt6 of the 3 and o isomers wErE the
least toxic end were co mparab l e to each other.

Toxicity

increased with the ethyl salts of both isow ers ,

althou~h

the ethyl salt of the 4 isomer was 3 times more toxic th a n
its counterp art.

As the carbon substitution incre 2se d from

two to seven carbons, the toxicity cf the 1-alkyl-3-benzoylpyridinium halides decr eassdo

From eight to Fifteen carbons

the toxicity of th ese compou nds rapidly increas edo
chang es in the

co~pounds,

Physical

decreasing water solubility and

increasing ability of an aqueous solution to foam when
agitated, paralleled the incr easing toxicity.
Th e symptoms of toxicity appeared to be th e same in
all cases:

d ecreased activity, myuriasis, dyspnea, rapidly

follo wed by convulsions

~nd

death.

The major change in

toxicity was the period of time required for death or
recov ery to occur.

Compound s containing une to eight
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carbon s caused death or recovery in one hour, while
co mpounds con taining nine to fifteen carbons

re ~uired

a

24 to 48 hour period for death or recovery.
The ch ange from

decr~asing

to increasin£ toxicity

paralleled by physical ch anges in the co mp ound s and the
~hang e

in mortality ti me eccompanying the above, su gges t

that ,th ere are t wo mechanisms of action for th ese

compounds~

The fi rst occu rs with the compounds containing one to sevsn
or eight c arbonsa
containing

~ore

than eight carbons and may be due in part

to surfac e active
Based

c~

The second occurs with the compounds

prop erties~

c ertain

pharmacolo~ical

principles, three

compoun ds representative of the 1-alkyl-3- benzo ylpyridinium
halides were chosen for further study:
and

3-C1 5-Br~

3-C2-I, 3-CB-Br,

Acut e intr aper iton ea l toxicities were

determin e d in albino

rats~

Although the gross syndrome

was similar to that of ths mice, it was int erest ing to note
the apparent chang e in t he trend qf toxicitye

3- C2-I was

three times more toxic in r ats whi le 3-CB-Br was
more toxic in

two

times

mice~

How e ve~,

since only three

co m ~ounds

had been tested

in r 2ts , the possibility existed as in the mice th at
bet ween 3-C2-I and 3-CB-Br the toxicity might incr ease
before decre asi ng.

Th erefore, t wo more

co w ~ounds,

3-C4-Br

and 3-CS-Br, were each te ste d in 18 wale albinG r a ts
em ploying thr ee do seso

More dos es and l arger groups were
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not employed due to the inavailability of sufficient amounts
of the compcurds.

Th ese two compounds were less toxic th an

3-C2-I, indic at ing that the trend in toxicity in both
species was somewhat similar but occurr e d at a slightly
differ ent number of carbonso

B.

BLOCD PRESSURE STUDIES-Rats
Direct blood pressure studies were conducted in male

albino rats because changes in blood pressure may indicate
a

dru~

action en the autonomic nervous system, on blood

ves se ls, on the heart, or the central nervous syst Em4
Intr avenous administration of 3-C2-I, 3-CS-Br, and
3-C1 5-Br result e d in a rapid but transient hypot e nsion.
Th e magnitude of the response v1as dose related while the
duration of the response ·was dose related for the latter
two compounds only.

The order of increasing hypotensive

effect was 3-C2-I, 3-CS-Br, and 3-C15-Br; the dur a tion of
th e response also increa se d in this orderc
The se compounds produc ed periods of dyspnea particat hig her doses and in some instances, normal furction was
restored with

~rtificial

respiration.

At higher doses of

3-C15-Br, the respir at ory passages were - filled
and artificial respiration was in e ffectivE.

~ith

fluid

This fluid

pheno meron did not occur with the other compounds

tested~

Respiratory f a il ure pr eceded cardia c arrest and death.

c.

BLO OQ. PRESSURI

STUDIES-Ca~

Observati on of the

and Doos

hypote~sive

effects cf these
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compound s led to the investigation of the modo of this action.
The pos sibility of a central action was not pursued because
quaternary ammonium salts do not readily traverse the blood
brain barrier.

Therefore, investigation of thE hypotensive

effects of thess compounds

~as

directed toward peripheral

actions.
The first possible site of actior inv estigated was
the autonomic nervous system, since this system exerts a
sig nifi cant controlling influence on blood pressure.

Four

cardiov ascular tests, mediated through the autonomic nervous
system, were performed in cats1

carotid occlusion, vagal

stimulation, administration of acetylcroline and epinephrine.
Carotid occlusion reflexly stimulates the sympathetic nerve
leadi ng to the heRrt through a central mechanism, which then
caus es

acceleration~

The blood vessels also constrict and

a rise in blood pressure ensueso

Electrical stimulation of

the peripheral portion of the severed vagus nerve is a
presynpatic stimulation of

E

parasympathetic

nerve~

whose

impul ses cause the heart rate to decrease End blood vessels
to dilate.

A fall in blood pressure ensues.

Ac etylcroline

c auses a fall in blooc pressure, epinephrine a rise in
blood pressure, due to their actions at the neuro-effector
junction of the parasympathetic
system,

syste~

a nd sympethetic

respectively~

Concurrert to the pe a k hypotensive Effect of 3-C2-I
or 3-C8-Br, the resporses to carotid occlusi on and vagal
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sti mu l ation were either decreased or abolishEd.

In most

ins tances th8 respons e to epinephrine was incre 2sed .

Thi s

su ggested that the hypotersive effects of th ese twc compo unds resclted from the i nterference of trans mission at
autonomic ganglia.

3-C8-Br was more effecti ve in this

r espect.
In travenous administration of 3-C15-B7

t~

c2ts

r esulted in death from r esp iratory failure probably due
in part to larg e 2mounts of red flui d in the respiratory
pa ssages~

Aspiration of the fluid and artificial respira-

tio r were not effective.

It was possible that this secretion

of fluid might be the re s ult of excessive use of acety lcholin e.

Therefore, two additional cats were prepared by

th e samE surgical proc edu re but were administered only
th e test compound.

Th e same response was noteda

3-C12-Br

was t ested in this manner with th e same resultso

Wi th all

fo ur co mpounds , respiratory failure preced ed c ar diac
arre st and death.
Some of t he high er molecular weight quaternary
ammonium s a lts are surface active agents and hav8 found
u se as antibacterial agents (j isinfecta~ts, artiseptics ,
or sanitizers).

Sinc e zqueous solutions of 3 C12-Br and

3-C15-Br produce foam when ag it ated , i t suggests that
t hese two compounds have similar prop2rties.

It is

po ssib l e that the excess fluid in the respiratory passages
resulted from an effect on-

membra~e

per~eability

concomitant
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with a hemolysis of red blood cells.
A~thcugh

3-C12-Br and 3-C15-Br exhibited hypotensive

effects preceding the appearance of fluid in the respiratory
passages, no pcsitive conclusions u:ere drawn concerning
their

~echanism

of action.

Fur th e r study of these compounds

was discontinued at this time.
D.

NICTITA TI NG MEMBRAN E
The nict1tating membrane is a

in certain animals.

th~rd

e yelid present

It is co mposed of smooth muscle and

is innervated by sympathetic fibers, only.

The pre- and

postganglionic fibers inn er va ting this membrane Gre re a dily
isolated, thereby making it an id ea l pr e para tion for testing sy mpathclytic and ganglioplegic agent s.
Prior testing ha d suQgested that 3-C2-I and 3- CB-Br
might be ganglioplegic agents.

This preparation was

employed to further test this sGpposition.
3-C2-I and 3-CB-Br were found to be

hypoten~ive

agents when administered intravenously to cats.

The

increasin g hypot en sion was accompanied by a decreased and
finally abolished re s ponse of the nictitating membrane to
stimulation of the preg a nglionic cervical Eym pathe tic
nerve.

The return of tlood pressure to normal was accompa-

nied by a recovery of the response of the nictitating
membrane to preganglioric stimulation.

The response to

postganglionic stimulation was unaffected.
vations

support the hypoth esis that

the~e

Th ese obsertwo compounds
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exsrt a hypotensive effect through ganglioplegia .

E.

filNDQLJARTER PERF-USION
Although previous tests had shown that 3-C2-I

and 3-CB-Br have ganglioplegic properties , these
esta~lished

procedures had not
comprised a

p~ssible

hypotensive effect.
activity ,
rats.

~i~dquarter

o~

wheth8r direct va sodilation

significant component

o~

the

ln order to test for vasodilator
parfusions wece performed in intact

The method employed permitted direct contact of the

compounds with the hindquarter vasculature but precluded
reflex control of the autonom ic nervous system.

Th~s

any change in flow rate would be due to a direct drug
action upon the vasculature.
The compounds were employed in doses up to the
equivalent ED5D.

A two tailed Student's t test at the

9S per.cent level rejected the hypothesis of a signif icant change in flow rate following
istration of the test compound.

~ntravenous

Thus these

admi n-

axperim~nt s

reject direct vasodilation as a significant component
the

hypo~ensive

F.

ISOLATED HEART PERFUSION

o~

effect.

Prio_ experimentat ion had estab li shed that 3-C2-I
and 3-CB-Br exerted a hypotensive effect resulting from
ganglio~legia

unabetted by significant direct vasodilation.

However, the possibility of a direct action upon the heart
contributin~

significantly to the hypotensive effect existed
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and was tested by employing an isolated hear£ preparation .
Perfusion of the coronary systeLl of an isolated heart has
the advantags of supplying the drug direct ly to the cardiac
muscle.

Howsver, this method is disadvantageous becEuse of

the inability to correlate the dose producing an effect on
the isolated heart with the dose producing an effect in the
intact an im a l.

It can establish whether there is a depres-

sant effect but not whether the cc.rdiac depression contrib-uted significantly to the overall hypotensive effect.
The principal ef fect of 3-C2-I on the i solated heart
was severe depression occurring from 0.5 to 4.0 mg .

The

principal effect of 3-CB-Br on the isolated heart was cardiac
srrest occurring from 0.6 to 1.0 mg .
tecame cardiotoxic.
of the

respo~se

At

2~0

mg the compound

Neither the magnitude nor the duration

to either compound were dose related.

Evaluated on the basis of c2rdiotoxicity , 3-CB-Br was
more toxic than 3-C2-Io

At 2.0 mg , the former produced

three out of three cardiac arrests with no recoveries ,
while the latter at the same dose

prod~ced

one out of

seven cardiac arrests with no recovery and five out of
ssven severe cardiac depressions with full recoveries.
Also noted in severa l inst ances with these compounds was an
initial increased amplitude of contraction, lasting 2 to
3 seconds preceding cardiac depression or arrest .
The results of these experimen ts indic ated that
these compounds have an effect on the heart.

No positive
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conclusions were drawn concerning this mechanism of action
or concerning the

contributio~

a nd significance of these

effects to the overcll hypotension .

56

V.
1.

SUMMARY AND CONCLUSIONS

A series of syntheti.c 1--alky'l-3- and 1-alkyl-4··

benzoylpyridinium halides · were screened for pharmacological
act ivity with the purpose of relating such activit y to their
structura l arrangement .

An attempt was made to determine

their mode of act iono
2.

In micG, the trend of the acute intraperitoneal

toxicity for the 1- a lkyl-3- benzo ylpyridinium halides was
biphasic.

The methyl halides of the 3 and 4 isowers were

found to be the l eas t toxic and comparable to eac h other .
The toxicity of the ethy l halides of these isomers was
incr ease d over that of the methyl halides, a lthough the 4
isom er was three ti mes more toxic than its counterpart.
As the carbon subst itution incr eased to seven in the 3
isomer, the toxicity decreased.

Increasing carbon substi-

tution resulted in incr easing toxicity.

This incr eas ing

toxicity was paralleled by an increasing ability of aqueous
solutions of these compounds to foam an d a decreasing wate r
s olubility .
3.

In rats the acute i ntraperitorsa l toxicity de-

cre ase d as the carbon substitution increased
five .

fro~

two to

From 3-C5-Br to 3-CB-Br, the toxicity rapi dly increased .
4.

In rats, the EDSO (h ypotensive ) increased from

3-C2-I to 3-CB-Br to 3-C15-Br.

A dose-effect relationship
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Higher doses of 3-C15-Br resulted in death from

existe~ .

respiratory failure, which may have been partly duG to
fluid in the respiratory pass ages .
5.

In cats and dogs , 3-C2-I and 3-CS-Br demonstrated

hypotensive effects .

The normal response to carotid occlu-

sion and vagal stimulation was decreased and the response to
injected epineph rine was increased suggesting ganglioplegia .
3-CE-Br was more potent than 3-C2-I in this ability .

In

cats, 3-C12-Br and 3-C15-Br in higher doses resulted in
respiratory failure probably due to excessive amounts of red
fluid in the respiratory passages.

The ability of aqueous

solutions of these compounds to foam suggests death resulted
from a change in membrane permeability concomitant with a
hemolysis of red blood cells.
6.

3-C2-I and 3-CB-Br blocked the normal response

of the nictitating membrane in cats to electrica l stimulation of the preganglioric cervical sympathetic nerveo

The

response of this membrane to pcstganglionic electr ical
stimulation was unaffected.

3-CS-Br was more potent in

this abilit y than 3-C2-I .
7.

Employing doses up to the equiva l ent ED50

( hypotensive) in rats did not affect the flow rate of
perfusions of the hind quarter vasculature of the intact
rat .
8.

These two compounds showad cardiodep ressa nt

and cardiotoxic effects on the isolated guinea pig heart.
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A dose-effect relationship was not apparent .

3-CB-Br was

more potent then 3-C2-I .
9.

The results of these experiments support the

hypothesis that 3-C2-I and 3-CB-Br exert a hypotensive
effect through ganglioplegia unabetted by direct vasodilationg

A depressant action on the heart may contribute

to the hypotension induced by ganglioplegia .
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